NRTSF Nobilis Health (PNK) down 99.97% 12 Mar 2026: liquidity risk

NRTSF stock plunged -99.97% in market hours on 12 Mar 2026, trading near $0.00003 USD on the PNK exchange in the United States. The fall follows a collapse from a previous close of $0.08041 USD, producing negligible intraday volume of 657 shares. We examine trading flow, valuation metrics, and near-term implications for investors in this top losers pick.

NRTSF stock: market move and trading snapshot

NRTSF stock closed the previous session at $0.08041 USD and moved to about $0.00003 USD during market hours on 12 Mar 2026. That is a -99.97% one-day change with reported volume 657 versus an average volume of 31,802. The tiny market cap reads $1,956.00 USD, reflecting severe illiquidity on the PNK market.

NRTSF stock news and drivers behind the drop

There is no single public filing explaining the slide at time of writing. Thin OTC trading and a large gap between bid and ask can produce swings like this. We reviewed recent company commentary and found no new positive catalysts, increasing the likelihood the move reflects execution of sell orders or quote adjustments rather than operating changes. For filings and company notices see the OTC Markets profile and SEC filings for Nobilis Health source source.

NRTSF stock fundamentals and valuation metrics

Nobilis Health Corp. reports EPS $0.02 USD and TTM revenue per share $3.85 USD. The firm sits in Healthcare, Medical – Care Facilities, and lists 78,250,465 shares outstanding. Key ratios show a current ratio near 2.12, debt to equity 0.91, and book value per share $2.54 USD. Price-based multiples are not meaningful given the quote collapse; market-based PE and PB ratios are distorted by the penny quote and low market cap.

Meyka AI rates NRTSF with a score out of 100: grade and technical view

Meyka AI rates NRTSF with a score out of 100: 67.31, Grade B, Suggestion HOLD. This grade factors in S&P 500 comparison, sector performance, financial growth, key metrics, and analyst consensus. Technical indicators show extremely limited data; intraday metrics flagged a pronounced abnormal move and RSI readings are unreliable given the quote collapse. We treat the technicals as noisy because volume is tiny relative to average.

NRTSF stock risks, catalysts and short-term outlook

Immediate risks: extreme illiquidity, quote instability on PNK, and potential delisting or corporate action. Catalysts that could stabilize price include audited filings, management updates, or a formal corporate notice. Sector context: Healthcare service names can recover on concrete operational improvements, but NRTSF’s trading profile amplifies volatility. We recommend monitoring official filings and market notices closely before sizing positions.

Final Thoughts

Key takeaways: NRTSF stock showed an extreme intraday collapse to about $0.00003 USD on 12 Mar 2026, producing a -99.97% change and highlighting severe liquidity risk on the PNK exchange in the United States. Fundamentals show positive operating cash flow per share and book value per share near $2.54 USD, but price discovery is broken by the penny quote. Meyka AI’s forecast model projects a near-term reference level of $0.00010 USD, implying an ~300.00% upside from the current quote. Forecasts are model-based projections and not guarantees. Given the distorted market price, we treat any price target with caution and urge investors to wait for confirmed corporate disclosures or higher quoting liquidity before re-entering. Meyka AI provides this as part of our AI-powered market analysis platform, but this is not investment advice.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.